Table 3

Multivariate Analysis of Patient and Clinician Factors That Influenced IPHR Use

VariableAdjusted OR (95% CI)
Patient age1.01 (1.01–1.01)
Patient sex (female vs male)1.09 (1.03–1.15)
Patient race
 Asian vs white1.18 (1.09–1.27)
 Black vs white0.89 (0.80–0.98)
 Hispanic vs white0.36 (0.18–0.73)
 Other vs white0.75 (0.58–0.96)
Patient’s comorbidities (none vs any)0.67 (0.63–0.71)
Clinician sex (female vs male)1.37 (1.26–1.49)
Clinician age, y
 25–34 vs 35–540.72 (0.66–0.80)
 55+ vs 35–540.63 (0.55–0.72)
Clinician, resident status
 Nonresident vs resident0.96 (0.86–1.08)
Clinician: early adoptera
 Agree vs disagree1.58 (1.44–1.73)
 Neither vs disagree1.27 (1.16–1.38)
Clinician: trainingb
 Agree vs disagree1.41 (1.29–1.54)
 Neither vs disagree0.84 (0.76–0.94)
Clinician: confidencec
 Agree vs disagree1.96 (1.75–2.19)
 Neither vs disagree0.83 (0.75–0.92)
  • IPHR = interactive prevention health record; OR = odds ratio.

    Notes: Values adjusted for patient and clinician characteristics, as well as practice. Only statistically significant variables were included in the final multivariate analyses.

  • a “Among my colleagues, I am usually one of the first to find out about a new test or treatment (strongly agree) (agree) (neither agree nor disagree) (disagree) (strongly disagree).” Reported by clinicians 1 year after fielding the IPHR.

  • b “The training I received about MyPreventiveCare was adequate (strongly agree) (agree) (neither agree nor disagree) (disagree) (strongly disagree).” Reported by clinicians 1 year after fielding the IPHR.

  • c “I feel confident in my ability to use MyPreventiveCare (strongly agree) (agree) (neither agree nor disagree) (disagree) (strongly disagree).” Reported by clinicians 1 year after fielding the IPHR.